Drug Shortage Report for VIRACEPT -250MG
Report ID | 65178 |
Drug Identification Number | 02238617 |
Brand name | VIRACEPT -250MG |
Common or Proper name | Viracept |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NELFINAVIR |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 1x300 BTL |
ATC code | J05AE |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-05-31 |
Actual start date | 2019-05-31 |
Estimated end date | 2019-07-05 |
Actual end date | 2019-07-05 |
Shortage status | Resolved |
Updated date | 2019-07-06 |
Company comments | Distributed by ViiV Healthcare. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2018-10-22 | English | Compare |
v1 | 2018-10-22 | English | Compare |